Trial Information

Summary: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

An International, Randomized, Double-Blind, Parallel, Placebo-Controlled, Flexible Dose Study: Evaluation of the Safety and Efficacy of Brivaracetam in Subjects (≥ 16 to 70 Years Old) Suffering From Localization-Related or Generalized Epilepsy.

This study will compare the safety and efficacy of brivaracetam at flexible dose with placebo in subjects suffering from epilepsy.

Inclusion Criteria:

• Male or female between 16 and 70 years old.
• Well-characterized localization-related or generalized epileptic syndrome, according to ILEA
• Unsatisfactory AED treatment despite treatment with up to 3 concomitant AEDs

Exclusion Criteria:

• Subjects suffering from undetermined epilepsy or special syndrome.
• History of status epilepticus
• History/presence of pseudoseizures.
• Progressive CNS disorder
• Other serious uncontrolled disease

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:43:22 AM